Compra con Hasta 70% dcto en los CyberBooks  Ver más

Enviar a
Bogota, Cundinamarca
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

portada Handbook of Pharmacogenomics and Stratified Medicine (en Inglés)
Formato
Libro Físico
Idioma
Inglés
N° páginas
1118
Encuadernación
Tapa Dura
ISBN13
9780123868824

Handbook of Pharmacogenomics and Stratified Medicine (en Inglés)

Sandosh Padmanabhan (Autor) · Academic Pr Inc · Tapa Dura

Handbook of Pharmacogenomics and Stratified Medicine (en Inglés) - Sandosh Padmanabhan

Libro Nuevo Importado
Envío: 18 a 22 días háb.
$ 1.246.562$ 685.609
-45%
Costos de importación incluídos en el precio ✅
Libro Nuevo

Quedan 100 unidades

$ 685.609
¡Envío Gratis!  Llega entre el 01 Sep y el 08 Sep a Bogota, Cundinamarca. Seleccionar ubicación

Reseña del libro "Handbook of Pharmacogenomics and Stratified Medicine (en Inglés)"

Handbook of Pharmacogenomics and Stratified Medicine is a comprehensive resource to understand this rapidly advancing field aiming to deliver the right drug at the right dose to the right patient at the right time. It is designed to provide a detailed, but accessible review of the entire field from basic principles to applications in various diseases. The chapters are written by international experts to allow readers from a wide variety of backgrounds, clinical and non-clinical (basic geneticists, pharmacologists, clinicians, trialists, industry personnel, ethicists) to understand the principles underpinning the progress in this area, the successes, failures and the challenges ahead. To be accessible to the widest range of readers, the clinical application section introduces the disease process, existing therapies, followed by pharmacogenomics and stratified medicine details. Medicine is the cornerstone of modern therapeutics prescribed on the basis that its benefit should outweigh its risk. It is well known that people respond differently to medications and in many cases the risk-benefit ratio for a particular drug may be a gray area. The last decade has seen a revolution in genomics both in terms of technological innovation and discovering genetic markers associated with disease. In parallel there has been steady progress in trying to make medicines safer and tailored to the individual. This has occurred across the whole spectrum of medicine, some more than others. In addition there is burgeoning interest from the pharmaceutical industry to leverage pharmacogenomics for more effective and efficient clinical drug development.

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Dura.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes